Evidence map›Paper›PMID 38155330›Full record

SynthesisNature genetics2024

Multi-ancestry genome-wide association meta-analysis of Parkinson's disease.

Jonggeol Jeffrey Kim, Dan Vitale, Diego Véliz Otani, Michelle Mulan Lian, Karl Heilbron, 23andMe Research Team, Hirotaka Iwaki, Julie Lake, Caroline Warly Solsberg, Hampton Leonard and 10 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Genetic Landscape of Monogenic Parkinson's Disease in the African Population-A Systematic Review.Movement disorders : official journal of the Movement Disorder Society · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Article
  11. Cellular and systemic modifiers of alpha-synuclein proteostasis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Shared genetic architecture between DTI-ALPS traits and neurodegenerative diseases.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jonggeol Jeffrey Kim *Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. kimjoj@nih.gov.ORCID http://orcid.org/0000-0003-0738-0512
Dan Vitale *Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Diego Véliz Otani *Neurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru.
Michelle Mulan Lian *Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore.
Karl Heilbron23andMe, Inc., Sunnyvale, CA, USA.
23andMe Research Team
Hirotaka IwakiLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Julie LakeLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Caroline Warly SolsbergPharmaceutical Sciences and Pharmacogenomics, UCSF, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-7049-6281
Hampton LeonardLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Mary B MakariousLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-7978-1051
Eng-King TanDepartment of Neurology, National Neuroscience Institute, Duke NUS Medical School, Singapore, Singapore.ORCID http://orcid.org/0000-0003-2977-9743
Andrew B SingletonLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Sara Bandres-CigaLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Alastair J NoycePreventive Neurology Unit, Centre for Prevention Diagnosis and Detection, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Global Parkinson’s Genetics Program (GP2)
Cornelis BlauwendraatLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. cornelis.blauwendraat@nih.gov.ORCID http://orcid.org/0000-0001-9358-8111
Mike A NallsLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. mike@datatecnica.com.ORCID http://orcid.org/0000-0003-0319-4325
Jia Nee FooLee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, Singapore. jianee.foo@ntu.edu.sg.
Ignacio MataGenomic Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. matai@ccf.org.

Funding

Genome wide SNP analysis in Parkinson's diseaseZIAAG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2024
$12.6M
Modeling the impact of Women's Specific Health Factors in PD outcomes in LatinasR01NS112499 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI FERNANDEZ MATA, IGNACIO · 2020 to 2024
$3.3M
Intramural NIH HHS ZIA AG000949NINDS NIH HHS R01 NS112499
6 · The paper itself

Abstract

Although over 90 independent risk variants have been identified for Parkinson's disease using genome-wide association studies, most studies have been performed in just one population at a time. Here we performed a large-scale multi-ancestry meta-analysis of Parkinson's disease with 49,049 cases, 18,785 proxy cases and 2,458,063 controls including individuals of European, East Asian, Latin American and African ancestry. In a meta-analysis, we identified 78 independent genome-wide significant loci, including 12 potentially novel loci (MTF2, PIK3CA, ADD1, SYBU, IRS2, USP8, PIGL, FASN, MYLK2, USP25, EP300 and PPP6R2) and fine-mapped 6 putative causal variants at 6 known PD loci. By combining our results with publicly available eQTL data, we identified 25 putative risk genes in these novel loci whose expression is associated with PD risk. This work lays the groundwork for future efforts aimed at identifying PD loci in non-European populations.

Indexed as

Genome-Wide Association StudyParkinson DiseaseGenetic Predisposition to DiseaseHumansPolymorphism, Single NucleotideUbiquitin ThiolesteraseUbiquitin ThiolesteraseUSP25 protein, human

Identifiers

PMID38155330
PMCPMC10786718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.